Index
1 Market Overview of Gravid Treatment
1.1 Gravid Treatment Market Overview
1.1.1 Gravid Treatment Product Scope
1.1.2 Gravid Treatment Market Status and Outlook
1.2 Global Gravid Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Gravid Treatment Market Size by Region (2018-2029)
1.4 Global Gravid Treatment Historic Market Size by Region (2018-2023)
1.5 Global Gravid Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Gravid Treatment Market Size (2018-2029)
1.6.1 North America Gravid Treatment Market Size (2018-2029)
1.6.2 Europe Gravid Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Gravid Treatment Market Size (2018-2029)
1.6.4 Latin America Gravid Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Gravid Treatment Market Size (2018-2029)
2 Gravid Treatment Market by Type
2.1 Introduction
2.1.1 Topical Products
2.1.2 Lasers
2.1.3 Microdermabrasion
2.1.4 Others
2.2 Global Gravid Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Gravid Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Gravid Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Gravid Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Gravid Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Gravid Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Gravid Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Gravid Treatment Revenue Breakdown by Type (2018-2029)
3 Gravid Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Specialty Dermatology Centers
3.1.4 Home-use
3.1.5 Others
3.2 Global Gravid Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Gravid Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Gravid Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Gravid Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Gravid Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Gravid Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Gravid Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Gravid Treatment Revenue Breakdown by Application (2018-2029)
4 Gravid Treatment Competition Analysis by Players
4.1 Global Gravid Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gravid Treatment as of 2022)
4.3 Date of Key Players Enter into Gravid Treatment Market
4.4 Global Top Players Gravid Treatment Headquarters and Area Served
4.5 Key Players Gravid Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Gravid Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Laboratoires Expanscience
5.1.1 Laboratoires Expanscience Profile
5.1.2 Laboratoires Expanscience Main Business
5.1.3 Laboratoires Expanscience Gravid Treatment Products, Services and Solutions
5.1.4 Laboratoires Expanscience Gravid Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 Laboratoires Expanscience Recent Developments
5.2 Clarins Group
5.2.1 Clarins Group Profile
5.2.2 Clarins Group Main Business
5.2.3 Clarins Group Gravid Treatment Products, Services and Solutions
5.2.4 Clarins Group Gravid Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Clarins Group Recent Developments
5.3 Merz North America, Inc. (Merz Group)
5.3.1 Merz North America, Inc. (Merz Group) Profile
5.3.2 Merz North America, Inc. (Merz Group) Main Business
5.3.3 Merz North America, Inc. (Merz Group) Gravid Treatment Products, Services and Solutions
5.3.4 Merz North America, Inc. (Merz Group) Gravid Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 E.T. Browne Drug Recent Developments
5.4 E.T. Browne Drug
5.4.1 E.T. Browne Drug Profile
5.4.2 E.T. Browne Drug Main Business
5.4.3 E.T. Browne Drug Gravid Treatment Products, Services and Solutions
5.4.4 E.T. Browne Drug Gravid Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 E.T. Browne Drug Recent Developments
5.5 Cynosure
5.5.1 Cynosure Profile
5.5.2 Cynosure Main Business
5.5.3 Cynosure Gravid Treatment Products, Services and Solutions
5.5.4 Cynosure Gravid Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Cynosure Recent Developments
5.6 Syneron Medical Ltd.
5.6.1 Syneron Medical Ltd. Profile
5.6.2 Syneron Medical Ltd. Main Business
5.6.3 Syneron Medical Ltd. Gravid Treatment Products, Services and Solutions
5.6.4 Syneron Medical Ltd. Gravid Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 Syneron Medical Ltd. Recent Developments
5.7 Union-Swiss (Pty) Ltd.
5.7.1 Union-Swiss (Pty) Ltd. Profile
5.7.2 Union-Swiss (Pty) Ltd. Main Business
5.7.3 Union-Swiss (Pty) Ltd. Gravid Treatment Products, Services and Solutions
5.7.4 Union-Swiss (Pty) Ltd. Gravid Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 Union-Swiss (Pty) Ltd. Recent Developments
5.8 Basq Skincare
5.8.1 Basq Skincare Profile
5.8.2 Basq Skincare Main Business
5.8.3 Basq Skincare Gravid Treatment Products, Services and Solutions
5.8.4 Basq Skincare Gravid Treatment Revenue (US$ Million) & (2018-2023)
5.8.5 Basq Skincare Recent Developments
5.9 Ellipse A/S
5.9.1 Ellipse A/S Profile
5.9.2 Ellipse A/S Main Business
5.9.3 Ellipse A/S Gravid Treatment Products, Services and Solutions
5.9.4 Ellipse A/S Gravid Treatment Revenue (US$ Million) & (2018-2023)
5.9.5 Ellipse A/S Recent Developments
5.10 The Boppy Company
5.10.1 The Boppy Company Profile
5.10.2 The Boppy Company Main Business
5.10.3 The Boppy Company Gravid Treatment Products, Services and Solutions
5.10.4 The Boppy Company Gravid Treatment Revenue (US$ Million) & (2018-2023)
5.10.5 The Boppy Company Recent Developments
5.11 Helix BioMedix
5.11.1 Helix BioMedix Profile
5.11.2 Helix BioMedix Main Business
5.11.3 Helix BioMedix Gravid Treatment Products, Services and Solutions
5.11.4 Helix BioMedix Gravid Treatment Revenue (US$ Million) & (2018-2023)
5.11.5 Helix BioMedix Recent Developments
5.12 Weleda AG
5.12.1 Weleda AG Profile
5.12.2 Weleda AG Main Business
5.12.3 Weleda AG Gravid Treatment Products, Services and Solutions
5.12.4 Weleda AG Gravid Treatment Revenue (US$ Million) & (2018-2023)
5.12.5 Weleda AG Recent Developments
5.13 Dermaclara
5.13.1 Dermaclara Profile
5.13.2 Dermaclara Main Business
5.13.3 Dermaclara Gravid Treatment Products, Services and Solutions
5.13.4 Dermaclara Gravid Treatment Revenue (US$ Million) & (2018-2023)
5.13.5 Dermaclara Recent Developments
5.14 Mama Mio US
5.14.1 Mama Mio US Profile
5.14.2 Mama Mio US Main Business
5.14.3 Mama Mio US Gravid Treatment Products, Services and Solutions
5.14.4 Mama Mio US Gravid Treatment Revenue (US$ Million) & (2018-2023)
5.14.5 Mama Mio US Recent Developments
5.15 Centre Light Solutions
5.15.1 Centre Light Solutions Profile
5.15.2 Centre Light Solutions Main Business
5.15.3 Centre Light Solutions Gravid Treatment Products, Services and Solutions
5.15.4 Centre Light Solutions Gravid Treatment Revenue (US$ Million) & (2018-2023)
5.15.5 Centre Light Solutions Recent Developments
6 North America
6.1 North America Gravid Treatment Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Gravid Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Gravid Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Gravid Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Gravid Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Gravid Treatment Market Dynamics
11.1 Gravid Treatment Industry Trends
11.2 Gravid Treatment Market Drivers
11.3 Gravid Treatment Market Challenges
11.4 Gravid Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List